Preparation to Closeout: How to Optimise Sponsor Oversight in Clinical Trial Vendor Management

Featured post image
Published: 2023/09/13 Last updated: 2023/10/31 By: Tom Lazenby

Sponsor oversight of vendor management is a critical aspect that requires attention, especially when dealing with subcontractors.

For clinical trial Sponsor organisations, managing subcontractors used by the primary vendor can be complex and filled with challenges. This blog post aims to shed light on how to optimise this process from preparation to closeout.

The Importance of Vendor Management in Clinical Trials

In the clinical trial landscape, vendors play a vital role in trial activities. When the sponsor delegates activities to the primary vendor, they may further delegate those tasks to subcontractors.

This delegation leads to a web of responsibilities that must be meticulously overseen to ensure compliance with regulatory requirements, as per ICH GCP and other applicable guidance and regulations.

Problems in Vendor Management

1. Delays: Emerging Issues Can Cause Significant Delays in the Trial

Emerging issues can range from contractual misunderstandings to unexpected regulatory obstacles or quality failures in deliverables. These lead to substantial delays in the timeline of a clinical trial.

In a large multi-site clinical trial, a key vendor failed to deliver necessary equipment on time due to a manufacturing error. This caused a chain reaction, delaying not only the deployment of the equipment but also the initiation of the trial at several sites.
Delays cause a domino effect, pushing back all stages of the trial. It can result in increased costs, wasted resources, and potentially loss of competitive advantage if other similar trials reach completion first.

2. Visibility: Tracking Vendor Subcontractors Can Be Challenging

When vendors subcontract tasks to third parties, keeping track of these subcontractors’ activities, performance, and compliance becomes more complex in terms of oversight and coordination.

A pharmaceutical company was unaware that one of their primary vendors had subcontracted a critical component of a trial to another vendor. The lack of visibility led to a situation where the quality of the subcontractor’s work was subpar and went unnoticed until a late stage.
Lack of visibility into subcontractor activities can lead to quality issues going undetected, potentially resulting in regulatory non-compliance, reputational damage, and ultimately, trial failure.

3. Compliance: Ensuring Subcontractor Protocol Compliance Can Be Intricate

Ensuring that subcontractors follow all required protocols, regulations, and quality standards can be a complicated task. It requires meticulous oversight and understanding of all applicable regulations.

A clinical trial faced regulatory scrutiny when a subcontractor failed to follow the required data privacy protocols, leading to a data breach.
Non-compliance with protocols can lead to legal and regulatory impacts, undermine the integrity of the trial data, and damage the reputation of the Sponsor organisation.

4. Sponsor Capabilities: Sponsors Might Struggle with Managing Oversight

Sponsors may lack expertise, resources, or internal processes needed to effectively manage and oversee their vendors. This can create confusion, miscommunication, and inconsistencies in vendor management.

A small biotech company, new to clinical trials, struggled to oversee a complex network of vendors. This lack of oversight capability led to confusion in roles, misaligned expectations, and inconsistency in deliverables.
Failure to manage vendor oversight can lead to a breakdown in communication and collaboration, resulting in inefficiencies, delays, and a higher risk of non-compliance with regulatory standards.

5. Lack of Procedures: Absence of Robust Procedures in Place for Vendor Management

Without robust procedures for vendor management, sponsors may face challenges in maintaining control, ensuring quality, and responding effectively to unexpected issues.

A global clinical trial Sponsor lacked a standardised procedure for vendor selection and performance monitoring. As a result, they ended up working with a vendor that did not meet their quality standards, causing delays and rework.
Absence of robust procedures leads to inconsistencies in vendor management, resulting in inefficiencies, quality issues, delays, and a higher risk of regulatory non-compliance. It hinders the organisation’s ability to respond swiftly, impacting the overall trial timeline and budget.

Sponsor Oversight: A Necessity in Vendor 3rd Party Management

Sponsor oversight is about a framework that ensures that the robust completion and documentation of a number of procedures as listed below, that ensure compliance, quality, communication and on time delivery from vendors and subcontractors.

Selection and Qualification

Selection and Qualification involve identifying and evaluating potential vendors to ensure they have the capabilities to fulfil the trial’s requirements. A rigorous examination of a vendor’s history, capabilities, financial stability, and compliance with industry standards, including a checklist of criteria, due diligence, references, and possibly on-site assessments.

Choosing the right vendors with proven expertise ensures that the trial gets off to a strong start, with vendors who are competent and aligned with the trial’s specific needs. This reduces the risk of issues related to inexperience or incompetence.

The proper selection and qualification of vendors protect the sponsor from potential pitfalls and liabilities. It ensures that the vendor’s goals align with those of the sponsor, increasing the likelihood of success and potentially speeding up the trial process.

Contracts and Deliverables

Contracts and Deliverables define the terms of the engagement between the Sponsor and the vendor. Implementation includes detailed contract with legal expertise and clearly communicating expectations to all parties involved.

Clearly defined contracts define the working relationship between Sponsor and vendor, reducing the potential for misunderstandings and conflicts that can lead to delays or quality issues.

A well-defined contract protects the Sponsor’s interests, providing a framework for resolving any disputes and ensuring that expectations are met, maintaining accountability and ensuring deliverables are met on time and in budget.

Performance Monitoring and Review

Performance Monitoring and Review involve continually assessing the vendor’s performance against agreed-upon standards, using KPIs and other metrics. This might include implementing real-time dashboards, regular status meetings, and periodic in-depth reviews. Regular monitoring helps in quickly identifying and resolving issues.

Constant oversight ensures that the trial stays on track, with immediate detection and correction of any performance issues. It ensures consistency, quality, and adherence to timelines.

Effective performance monitoring enables better control and transparency in the vendor relationship. It enhances efficiency and provides actionable insights for continuous improvement, contributing to the overall success of the trial.

Communication and Approval

Communication and Approval encompass setting up clear channels of communication, feedback loops, and defined approval processes. Implementation includes scheduling regular check-ins, defining escalation paths, and using collaboration tools to facilitate clear and timely communication.

Transparent communication and a clear approval process enable faster decision-making and responsiveness, reducing potential delays and misunderstandings. It fosters collaboration and alignment between all parties involved.

Efficient communication enhances the relationship between the sponsor and the vendor, enabling them to work more cohesively. It ensures that decisions are made promptly and that everyone stays informed, contributing to the trial’s smooth progress.

Transfer of Regulatory Obligations

Transfer of Regulatory Obligations entails delegating specific regulatory responsibilities to the vendor while ensuring compliance with all applicable laws and regulations. This process requires an understanding of regulatory requirements, robust documentation, and ongoing monitoring to ensure vendor compliance. Implementation might include detailed contractual agreements outlining the transferred obligations and regular audits to ensure compliance.

Proper transfer of regulatory obligations ensures that all parties are clear on their specific roles and responsibilities regarding compliance. This clarity helps avoid regulatory missteps that can delay a trial.

Robust transfer of regulatory obligations safeguards the Sponsor against compliance risks. Enabling the Sponsor to leverage the vendor’s expertise in certain regulatory areas.

Best Practices for Handling Subcontractors: A Short Guide

Assessing and Monitoring Subcontractors

Assessing and monitoring subcontractors involves ongoing evaluation of performance and adherence to the main contract’s terms. This includes initial assessments to verify qualifications and capabilities, and continuous monitoring through periodic reviews, audits, and evaluations of key performance indicators (KPIs). Tools like real-time dashboards and automated reporting can facilitate this process.

Continuous assessment and monitoring ensure that subcontractors meet their obligations in terms of quality, timelines, and other contractual requirements. It aids the early identification of issues, enabling timely intervention to prevent delays or substandard delivery.

This enhances the Sponsor’s control and visibility, protecting against potential risks and issues. By ensuring that subcontractors meet expectations, it enhances overall trial quality and can improve relationships with primary vendors.

Communicating Subcontracting

Communicating subcontracting involves transparently sharing information about subcontracting arrangements, including roles, responsibilities, and progress updates. Regular communication, such as scheduled meetings, updates, or shared online platforms, helps keep all parties informed. Clearly documented communication protocols ensure that the right information reaches the right people at the right time.

Clear communication regarding subcontracting helps avoid misunderstandings and surprises that might delay the trial. It builds collaboration between all parties involved in the trial.

Open and regular communication enhances visibility and control for the Sponsor. It builds trust and confidence in the subcontracting relationships, reducing the risk of conflicts or oversights.

Ensuring Compliance with Regulatory Requirements

Ensuring compliance with regulatory requirements entails implementing rigorous processes to verify that subcontractors adhere to ICH GCP and other specific local regulations. This includes setting clear compliance expectations in contracts, conducting regular audits, and providing necessary training or guidance as needed. Robust documentation and reporting mechanisms are also essential to maintain compliance records.

Compliance with regulatory requirements is fundamental to the legitimacy and success of the trial. Regular monitoring and enforcement ensure that subcontractors uphold these standards, reducing the risk regulatory issues that might harm the trial outcomes.

The Sponsor can mitigate potential regulatory risks and findings. This reinforces the organisation’s reputation for integrity and quality. It ensures the scientific and ethical integrity of the trial is maintained, which is crucial for the acceptance and credibility of the trial’s results.

Wrapping Up: Building a Robust Vendor Management Framework

Vendor management in clinical trials involves many moving parts. Sponsors must have a robust framework in to optimize every stage of the process. This ensures compliance with regulatory requirements but also enhances efficiency.

3rd party management builds strong relationships with vendors, understanding their capabilities, setting clear expectations, continuously monitoring performance, and ensuring that all activities align with the overall goals of the clinical trial.

Putting these strategies into practice, Sponsors can avoid common pitfalls like delays caused by emerging issues, lack of visibility and tracking of vendor subcontractors, subcontractor protocol compliance issues, and lack of robust procedures.

In the delivery of clinical trials; preparation, diligence, and a proactive approach to vendor management are key. Collaborative relationships, transparency, and adherence to regulations form the bedrock of successful clinical trial vendor management.

Staying ahead requires expertise and the ability to adapt and innovate. Make vendor management a strategic asset in your clinical trials and watch how it transforms the way you conduct research.

Tom Lazenby

Tom is the Founder and CEO of Mayet. Using his experience in streamlining operations and driving innovation in clinical research, Tom is dedicated to enhancing the efficiency, cost-effectiveness, and risk mitigation strategies for vendor management and oversight.

See other posts »